Mark Dominik Alscher

4.4k total citations
164 papers, 2.4k citations indexed

About

Mark Dominik Alscher is a scholar working on Nephrology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Mark Dominik Alscher has authored 164 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Nephrology, 37 papers in Pulmonary and Respiratory Medicine and 27 papers in Surgery. Recurrent topics in Mark Dominik Alscher's work include Dialysis and Renal Disease Management (44 papers), Acute Kidney Injury Research (16 papers) and Viral Infections and Vectors (13 papers). Mark Dominik Alscher is often cited by papers focused on Dialysis and Renal Disease Management (44 papers), Acute Kidney Injury Research (16 papers) and Viral Infections and Vectors (13 papers). Mark Dominik Alscher collaborates with scholars based in Germany, Switzerland and United States. Mark Dominik Alscher's co-authors include Martin Kimmel, Niko Braun, Joerg Latus, U. Kuhlmann, Daniel Kitterer, Thomas Mettang, Péter Fritz, Dagmar Biegger, Christiane Pauli‐Magnus and Moritz Schanz and has published in prestigious journals such as The Lancet, Circulation and SHILAP Revista de lepidopterología.

In The Last Decade

Mark Dominik Alscher

150 papers receiving 2.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mark Dominik Alscher Germany 26 911 432 385 335 273 164 2.4k
Tevfik Ecder Türkiye 30 1.3k 1.4× 356 0.8× 480 1.2× 154 0.5× 100 0.4× 110 3.2k
Vandana Mathur United States 27 881 1.0× 400 0.9× 397 1.0× 347 1.0× 158 0.6× 89 3.3k
J. D. Briggs United Kingdom 29 824 0.9× 576 1.3× 404 1.0× 125 0.4× 80 0.3× 106 2.8k
Michelle Denburg United States 29 637 0.7× 283 0.7× 553 1.4× 74 0.2× 197 0.7× 110 2.6k
Gunnar Sterner Sweden 28 1.9k 2.1× 445 1.0× 592 1.5× 61 0.2× 213 0.8× 97 3.5k
Antonio Lupo Italy 40 1.5k 1.7× 623 1.4× 1.0k 2.7× 83 0.2× 138 0.5× 172 4.2k
Graziella Zacchello Italy 26 655 0.7× 377 0.9× 436 1.1× 75 0.2× 100 0.4× 79 2.1k
I‐Kuan Wang Taiwan 25 578 0.6× 318 0.7× 267 0.7× 36 0.1× 118 0.4× 140 2.1k
Yu‐Tzu Chang Taiwan 24 331 0.4× 181 0.4× 139 0.4× 94 0.3× 84 0.3× 115 1.6k
Cheng‐Chia Lee Taiwan 24 761 0.8× 321 0.7× 225 0.6× 45 0.1× 72 0.3× 120 1.9k

Countries citing papers authored by Mark Dominik Alscher

Since Specialization
Citations

This map shows the geographic impact of Mark Dominik Alscher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Dominik Alscher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Dominik Alscher more than expected).

Fields of papers citing papers by Mark Dominik Alscher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Dominik Alscher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Dominik Alscher. The network helps show where Mark Dominik Alscher may publish in the future.

Co-authorship network of co-authors of Mark Dominik Alscher

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Dominik Alscher. A scholar is included among the top collaborators of Mark Dominik Alscher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Dominik Alscher. Mark Dominik Alscher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alscher, Mark Dominik, et al.. (2025). The impact of C-level positions on hospital performance: A scoping review of top management team outcomes. Health Policy. 157. 105346–105346.
2.
Schricker, Severin, et al.. (2025). Effects of a Mind-Body Medicine Group Program for Cancer Patients: A Retrospective Cohort Study. Integrative Cancer Therapies. 24. 1583693192–1583693192.
3.
Alscher, Mark Dominik, et al.. (2024). Impact of C-level positions on hospital performance: a scoping review protocol. BMJ Open. 14(7). e085655–e085655. 1 indexed citations
4.
Schanz, Moritz, Oliver Schöffski, Martin Kimmel, et al.. (2021). Under-recognition of Acute Kidney Injury after Cardiac Surgery in the ICU Impedes Early Detection and Prevention. Kidney & Blood Pressure Research. 47(1). 50–60. 13 indexed citations
5.
Alscher, Mark Dominik. (2021). Diuretika als Problem – Pharmakokinetik und -dynamik, Einsatz bei Ödemen oder Hypertonie. Der Internist. 62(2). 215–220.
6.
Schanz, Moritz, Severin Schricker, Frederick Pfister, Mark Dominik Alscher, & Martin Kimmel. (2018). Renal complications of cancer therapies. Drugs of today. 54(9). 561–561. 6 indexed citations
7.
Kitterer, Daniel, Dagmar Biegger, Stephan Segerer, et al.. (2017). Alteration of membrane complement regulators is associated with transporter status in patients on peritoneal dialysis. PLoS ONE. 12(5). e0177487–e0177487. 8 indexed citations
8.
Kitterer, Daniel, Ferruh Artunç, Stephan Segerer, et al.. (2015). Evaluation of lipase levels in patients with nephropathia epidemica - no evidence for acute pancreatitis. BMC Infectious Diseases. 15(1). 286–286. 8 indexed citations
9.
Latus, Joerg, Daniel Kitterer, Stephan Segerer, et al.. (2015). Determination of Procalcitonin Levels in Patients with Nephropathia Epidemica - A Useful Tool or an Unnecessary Diagnostic Procedure?. Kidney & Blood Pressure Research. 40(1). 22–30. 10 indexed citations
10.
Schroth, Werner, Stefan Winter, Florian Büttner, et al.. (2015). Clinical outcome and global gene expression data support the existence of the estrogen receptor-negative/progesterone receptor-positive invasive breast cancer phenotype. Breast Cancer Research and Treatment. 155(1). 85–97. 22 indexed citations
11.
Seeger, Harald, Niko Braun, Joerg Latus, et al.. (2014). Platelet-Derived Growth Factor Receptor-β Expression in Human Peritoneum. Nephron Clinical Practice. 128(1-2). 178–184. 8 indexed citations
12.
Latus, Joerg, et al.. (2014). Severe thrombocytopenia in hantavirus-induced nephropathia epidemica. Infection. 43(1). 83–87. 20 indexed citations
13.
Fritz, Péter, Klaus Bendrat, Maike Sonnenberg, et al.. (2014). Tubular breast cancer. A retrospective study.. PubMed. 34(7). 3647–56. 11 indexed citations
14.
Braun, Niko, Mark Dominik Alscher, Péter Fritz, et al.. (2013). Periostin: A Matricellular Protein Involved in Peritoneal Injury during Peritoneal Dialysis. Peritoneal Dialysis International. 33(5). 515–528. 13 indexed citations
15.
Kimmel, Martin, Niko Braun, & Mark Dominik Alscher. (2011). Influence of Thyroid Function on Different Kidney Function Tests. Kidney & Blood Pressure Research. 35(1). 9–17. 59 indexed citations
16.
Kimmel, Martin, et al.. (2010). Should we recommend precautions during a hantavirus endemic?. Clinical Kidney Journal. 3(4). 424–426. 2 indexed citations
17.
Alscher, Mark Dominik. (2009). Herz und Niere. Der Kardiologe. 3(6). 489–498. 1 indexed citations
18.
Kimmel, Martin, et al.. (2007). Improved estimation of glomerular filtration rate by serum cystatin C in preventing contrast induced nephropathy by N-acetylcysteine or zinc--preliminary results. Nephrology Dialysis Transplantation. 23(4). 1241–1245. 31 indexed citations
19.
Alscher, Mark Dominik, et al.. (2001). Cure of lifelong fatigue by calcium supplementation. The Lancet. 358(9285). 888–888. 2 indexed citations
20.
Alscher, Mark Dominik, Christiane Pauli‐Magnus, U. Kuhlmann, & Thomas Mettang. (2000). Stimulated IFNγ and IL‐10 Secretion of Blood Mononuclear Cells in Patients on Renal Replacement Therapies Show Different Secretion Patterns. Artificial Organs. 24(10). 767–772. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026